NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)
$350,000
HHS-NIH11
POSTED: 12/02/2024
UPDATED: 12/02/2024
DUE: 11/13/2026
This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated mid-phase clinical trials of natural products(i.e., botanicals, dietary supplements, and probiotics), which...
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
$1,050,000
HHS-NIH11
POSTED: 12/02/2024
UPDATED: 12/02/2024
DUE: 11/13/2026
This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated, early phase, clinical trials of natural products (i.e., botanicals, dietary supplements, and probiotics), ...
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
$350,000
HHS-NIH11
POSTED: 12/02/2024
UPDATED: 12/02/2024
DUE: 11/13/2026
This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated, early phase, clinical trials of natural products (i.e., botanicals, probiotics, and products marketed as d...
Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 12/02/2024
UPDATED: 12/02/2024
DUE: 01/07/2028
The purpose of this notice of funding opportunity (NOFO) is to support the investigation of HIV-1 Envelope (Env) cell surface expression, the structural mechanism of biologic-mediated cell killing, an...
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
$200,000
HHS-NIH11
POSTED: 12/02/2024
UPDATED: 12/02/2024
DUE: 11/16/2027
This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through ...
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
HHS-NIH11
POSTED: 12/02/2024
UPDATED: 12/02/2024
DUE: 11/16/2027
This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through ...
NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U44-Clinical Trial Required)
HHS-NIH11
POSTED: 12/01/2023
UPDATED: 12/01/2023
DUE: 01/07/2027
The NEI uses this U44 Notice of Funding Opportunity to support SBIR grant applications from small business concerns (SBCs) that propose to implement investigator-initiated, early-stage clinical trials...
Enhancement and Management of Established Biomedical Data Repositories and Knowledgebases (U24 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 08/30/2023
UPDATED: 08/31/2023
DUE: 01/25/2026
The purpose of this Notice of Funding Opportunity (NOFO) is to support established biomedical data resources, that have demonstrated impact and have potential for continued benefit to the mission of o...
Early-stage Biomedical Data Repositories and Knowledgebases (R24 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 08/30/2023
UPDATED: 08/31/2023
DUE: 01/25/2026
This Funding Opportunity Announcement (FOA) supports the development of early-stage or new data repositories and knowledgebases as distinct and separate resources that could be valuable for the biomed...
NLM Information Resource Grants to Reduce Health Disparities and Promote Health for All (G08 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 08/28/2024
UPDATED: 03/31/2025
DUE: 05/25/2026
This Notice of Funding Opportunity Announcement (NOFO) solicits resource grant applications for projects that will provide accurate, useful, usable, and understandable health information to population...